Clinical experience with sodium valproate in children

Area of Science:

• Pediatric Neurology
• Clinical Pharmacology

Background:

• Recurrent epileptic seizures in children pose significant management challenges.
• Identifying effective and well-tolerated anti-epileptic drugs is crucial for pediatric care.

Purpose of the Study:

• To evaluate the efficacy and tolerability of sodium valproate in children with severe, recurrent epileptic seizures.
• To assess the effectiveness of sodium valproate across different epilepsy syndromes.

Main Methods:

• A sample of 62 children with severe recurrent epileptic seizures was treated with sodium valproate (Epilim).
• Efficacy was assessed by seizure control, and concurrent anti-convulsant use was recorded.
• Side-effects were monitored throughout the study period.

Main Results:

• Sodium valproate achieved good seizure control in 44 (71%) of the children.
• The medication was most effective for petit mal seizures but also showed benefits in grand mal, psychomotor, and myoclonic seizures.
• Most children required minimal or no additional anti-convulsant medication, and side-effects were infrequent and mild.

Conclusions:

• Sodium valproate is an effective and generally well-tolerated treatment for severe childhood epilepsy.
• Its broad efficacy across seizure types makes it a valuable therapeutic option.
• The primary limitation for wider use in South Africa is the high cost of the medication.